phone
Contact
Discover Connective Tissue Supplementation
Call Us1.800.891.3452

News

Novel Use: Umbilical Cord Tissue in Sacral Ulcers

Jan 10, 2023

Click Here to Read the Case Study

Abstract

Each year, thousands of patients suffer from sacral decubitus ulcers, also known as pressure ulcers or sores. The current standard of care for sacral decubitus ulcer treatment is expensive and suboptimal, ranging in cost from a 15-dollar tube of Neosporin Ointment to 240,000 dollars for a skin flap surgery. Grade II pressure sores inevitably progress to stage III and IV if not addressed aggressively and early. Late-stage pressure sores present a unique challenge to physicians, particularly when they are deep, tunneling, and have tendon or bone involvement, as is the case for the two patients in this case study.

The first patient in this study (referred to as patient 1) was afflicted with a mid-sacral pressure sore with exposed tendon, bone, and tunneling of ten years duration. The second patient in this study (referred to as patient 2) suffered from an ischial pressure sore with exposed tendon, bone, and tunneling for 30 months duration. Both patients exhausted conservative measures, including wound vac placement, oral and IV antibiotic treatment, multiple episodes of sharp debridement, wet-to-dry dressings, silver sulfadiazine dressings, and dehydrated amniotic membrane allograft placements. After failing conservative management, both patients received several applications of Wharton’s Jelly, a Mesenchymal Connective Tissue allograft (MCT), to accelerate wound closure. Conservative management, including sharp debridement, oral antibiotics, and electrical stimulation, was used in conjunction with the WJ allograft applications.

At the time of consultation with Dr. Michael Lavor, both patients had Sacral Decubitus Ulcers (SDU) classified as Stage IV with tissue loss and involvement of bone or tendon, according to the National Pressure Ulcer Advisory Panel (NPUAP). After eight months of standardized wound care treatment combined with six Wharton’s Jelly allograft applications, both patients had wounds showing over 90% contraction in depth, tunneling, and diameter.

This case study demonstrates a precedent for applying Wharton’s Jelly allografts in late-stage sacral decubitus ulcers with associated tunneling in combination with standard of care. Future research efforts with Wharton’s Jelly allografts applied to recalcitrant wounds may be directed at the frequency and combination of procedural techniques that best promote granulation tissue formation and volumetric contracture of deep wounds by secondary intention.

Copyright
© 2023 Lavor M, et al. Distributed under Creative Commons CC-BY 4.0

How to cite this article
Lavor M, Shou J, Mobarak R, Lambert N, Barrett T. Novel Application of Umbilical Cord Flowable Tissue Allografts in Sacral Decubitus Ulcers: A Case Study. 2023 Jan 05; 4(1): 014-022. doi: 10.37871/jbres1644, Article ID: JBRES1644, Available at: https://www.jelsciences.com/articles/jbres1644.pdf

References

  1. Gefen A. Reswick and Rogers pressure-time curve for pressure ulcer risk. Part 1. Nurs Stand. 2009 Jul 15-21;23(45):64, 66, 68 passim. doi: 10.7748/ns2009.07.23.45.64.c7115. PMID: 19678520.
  2. Zaidi SRH, Sharma S. Pressure ulcer. In: StatPearls. StatPearls Publishing; 2021.
  3. Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res. 2010 Mar;89(3):219-29. doi: 10.1177/0022034509359125. Epub 2010 Feb 5. PMID: 20139336; PMCID: PMC2903966.
  4. Versluysen M. How elderly patients with femoral fracture develop pressure sores in hospital. Br Med J (Clin Res Ed). 1986 May 17;292(6531):1311-3. doi: 10.1136/bmj.292.6531.1311. PMID: 3085827; PMCID: PMC1340317.
  5. Gefen A. How much time does it take to get a pressure ulcer? Integrated evidence from human, animal, and in vitro studies. Ostomy Wound Manage. 2008 Oct;54(10):26-8, 30-5. PMID: 18927481.
  6. DerSarkissian C. Stages of pressure sores: Bed sore staging 1-4. WebMD. 2022.
  7. Au Y, Wang SC. Financial and Clinical Risk Evaluation of Pressure Injuries in US Hospitals: A Business Case for Initiating Quality Improvement. Wounds. 2019 May;31(5):123-126. PMID: 31033454.
  8. Scott S, Razzano L, Wong M. Reducing readmissions related to pressure ulcers-PPAHS. 2022.
  9. Brem H, Maggi J, Nierman D, Rolnitzky L, Bell D, Rennert R, Golinko M, Yan A, Lyder C, Vladeck B. High cost of stage IV pressure ulcers. Am J Surg. 2010 Oct;200(4):473-7. doi: 10.1016/j.amjsurg.2009.12.021. PMID: 20887840; PMCID: PMC2950802.
  10. Mervis JS, Phillips TJ. Pressure ulcers: Pathophysiology, epidemiology, risk factors, and presentation. J Am Acad Dermatol. 2019 Oct;81(4):881-890. doi: 10.1016/j.jaad.2018.12.069. Epub 2019 Jan 18. PMID: 30664905.
  11. Boyko TV, Longaker MT, Yang GP. Review of the Current Management of Pressure Ulcers. Adv Wound Care (New Rochelle). 2018 Feb 1;7(2):57-67. doi: 10.1089/wound.2016.0697. PMID: 29392094; PMCID: PMC5792240.
  12. Moretti E. Pressure ulceration; decubitus ulcers, pressure sores, bed sores. Cancer Therapy Advisor. 2022.
  13. Paker N, Buğdaycı D, Gökşenoğlu G, Akbaş D, Korkut T. Recurrence rate after pressure ulcer reconstruction in patients with spinal cord injury in patients under control by a plastic surgery and physical medicine and rehabilitation team. Turk J Phys Med Rehabil. 2018 Nov 6;64(4):322-327. doi: 10.5606/tftrd.2018.2175. PMID: 31453529; PMCID: PMC6648030.
  14. Kruger EA, Pires M, Ngann Y, Sterling M, Rubayi S. Comprehensive management of pressure ulcers in spinal cord injury: current concepts and future trends. J Spinal Cord Med. 2013 Nov;36(6):572-85. doi: 10.1179/2045772313Y.0000000093. Epub 2013 May 21. PMID: 24090179; PMCID: PMC3831318.
  15. Bennett RG, Bellantoni MF, Ouslander JG. Air-fluidized bed treatment of nursing home patients with pressure sores. J Am Geriatr Soc. 1989 Mar;37(3):235-42. doi: 10.1111/j.1532-5415.1989.tb06813.x. PMID: 2918193.
  16. Padula WV, Makic MB, Wald HL, Campbell JD, Nair KV, Mishra MK, Valuck RJ. Hospital-Acquired Pressure Ulcers at Academic Medical Centers in the United States, 2008-2012: Tracking Changes Since the CMS Nonpayment Policy. Jt Comm J Qual Patient Saf. 2015 Jun;41(6):257-63. doi: 10.1016/s1553-7250(15)41035-9. PMID: 25990891.
  17. Sobolewski K, Bańkowski E, Chyczewski L, Jaworski S. Collagen and glycosaminoglycans of Wharton’s jelly. Biol Neonate. 1997;71(1):11-21. doi: 10.1159/000244392. PMID: 8996653.
  18. Davis J, Martin S, Sheinkop M, Barrett T. Evaluation of the efficacy of cryopreserved human umbilical cord tissue allograft for the supplementation of cartilage defects associated to knee osteoarthritis: An observational data collection study. Preprints. 2022;2022070337. doi: 10.20944/preprints202207.0337.v1.
  19. Kamolz LP, Keck M, Kasper C. Wharton’s jelly mesenchymal stem cells promote wound healing and tissue regeneration. Stem Cell Res Ther. 2014 May 2;5(3):62. doi: 10.1186/scrt451. PMID: 25157597; PMCID: PMC4055121.
  20. Arno AI, Amini-Nik S, Blit PH, Al-Shehab M, Belo C, Herer E, Tien CH, Jeschke MG. Human Wharton’s jelly mesenchymal stem cells promote skin wound healing through paracrine signaling. Stem Cell Res Ther. 2014 Feb 24;5(1):28. doi: 10.1186/scrt417. PMID: 24564987; PMCID: PMC4055091.
  21. Meglin A, Shou J, Welch K, Vinke E, Lambert N, Barrett T. Application of umbilical cord tissue allografts in reduction mammoplasty wound: A case study. J Biomed Res Environ Sci. 2022 Dec 12;3(12):1495-1499. doi: 10.37871/jbresjbres1623.
  22. Berg W, Traneroth C, Gunnarsson A, Lossing C. A method for measuring pressure sores. Lancet. 1990 Jun 16;335(8703):1445-6. doi: 10.1016/0140-6736(90)91459-n. PMID: 1972219.
  23. Hocking AM, Gibran NS. Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. Exp Cell Res. 2010 Aug 15;316(14):2213-9. doi: 10.1016/j.yexcr.2010.05.009. Epub 2010 May 13. PMID: 20471978; PMCID: PMC2902653.
  24. Gupta A, El-Amin SF 3rd, Levy HJ, Sze-Tu R, Ibim SE, Maffulli N. Umbilical cord-derived Wharton’s jelly for regenerative medicine applications. J Orthop Surg Res. 2020 Feb 13;15(1):49. doi: 10.1186/s13018-020-1553-7. PMID: 32054483; PMCID: PMC7017504.
  25. Gonzalez AC, Costa TF, Andrade ZA, Medrado AR. Wound healing – A literature review. An Bras Dermatol. 2016 Sep-Oct;91(5):614-620. doi: 10.1590/abd1806-4841.20164741. PMID: 27828635; PMCID: PMC5087220.
  26. Alhajj M, Goyal A. Physiology, Granulation Tissue. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.
  27. Crabb RA, Chau EP, Decoteau DM, Hubel A. Microstructural characteristics of extracellular matrix produced by stromal fibroblasts. Ann Biomed Eng. 2006 Oct;34(10):1615-27. doi: 10.1007/s10439-006-9181-x. Epub 2006 Oct 3. PMID: 17016762.
  28. Davis J, Martin S, Purita J, Shou J, Barrett T. Three-dimensional electron microscopy of human umbilical cord tissue allograft pre and post processing: A literature comparison . Preprints. 2022;2022070297. doi: 10.20944/preprints202207.0297.v1.
View all Articles